BPC 157 For Knee Pain: Early Reported Outcomes, A report on intra articular BPC 157 for knee pain described high rates of improvement: ~92% with BPC 157 alone, ~75% when combined with thymosin beta 4, BPC 157 Dosing (Common Protocols), Oral Subcutaneous, 500 mcg daily, Duration: 6 weeks, Intramuscular Peritendinous, 1 mg daily, Duration: 6 weeks, Note:, Not approved by FDA or BPC 157 Peptide: Enhance Healing and Recovery Desert Mobile Medical Desert Mobile Medical, PLC Dosis para mezcla de BPC157 y TB500 BPC 157 Dosing (Common Protocols) Oral Subcutaneous 500 mcg daily Duration: 6 weeks Intramuscular Peritendinous 1 mg daily Duration: 6 weeks Note: Not approved The "Body Protection Compound": A Deep Dive into BPC 157 DiFrancesco Plastic Surgery